SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sommers, D. K.
Right arrow Articles by Avenant, J.C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sommers, D. K.
Right arrow Articles by Avenant, J.C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Antipyrine Metabolism in the Venda

De K. Sommers

Department of Pharmacology and Glaxo Institute for Clinical Pharmacology, University of Pretoria, PO Box 2034, Pretoria, South Africa

J. Moncrieff

Department of Pharmacology and Glaxo Institute for Clinical Pharmacology, University of Pretoria, PO Box 2034, Pretoria, South Africa

J.C. Avenant

Department of Pharmacology and Glaxo Institute for Clinical Pharmacology, University of Pretoria, PO Box 2034, Pretoria, South Africa

1 The excretion of antipyrine metabolites over 48 h as percentage dose and the antipyrine kel and metabolite formation rate constants have been measured for 20 healthy Venda Africans.

2 To allow comparison with published data from inter-ethnic studies with antipyrine, subjects were selected who had assumed a western life and diet.

3 The values (mean ± SE) for excretion of the metabolites, 4-hydroxyantipyrine (4OHA), norantipyrine (NORA) and 3-hydroxymethylantipyrine (3HMA) as percentage dose were 26.17 ± 0.34, 7.44 ± 0.34 and 13.28 ± 0.31 respectively. The total of the three metabolites was 49.56 ± 0.33. These results differ significantly from the values found for groups of Canadian students of Oriental and Caucasian backgrounds.

4 The values (mean ± SE) found for the antipyrine elimination rate constant and the metabolite formation rate constants of 4OHA, NORA and 3OHA were 6.56 (± 0.56) � 10 -2, 2.05 (± 0.24) x 10-2, 0.60 (± 0.09) x 10-2 and 1.06 (± 0.16) x 10-2 respectively. Only the NORA formation rate constant showed any significant difference with the results obtained for Americans, although the Venda exhibited a wider distribution of the 3HMA data.

5 The linearity of the probit plots obtained suggest that the subjects selected are homozygous for the oxidations investigated. The marked difference found in comparison with Caucasian and Oriental data on the one hand and American data on the other, also implies a marked difference between the Caucasian and Oriental data and the American data. Thus the relative contributions of environmental induction and heredity to these types of oxidation are still unclear and much work remains to be carried out in this field.

Human & Experimental Toxicology, Vol. 6, No. 2, 127-131 (1987)
DOI: 10.1177/096032718700600204


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement